Canada markets close in 2 hours 51 minutes

Acrivon Therapeutics, Inc. (ACRV)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.24+0.10 (+1.23%)
As of 01:09PM EDT. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts9999
Avg. Estimate-0.84-0.73-2.85-2.76
Low Estimate-0.97-1.05-4.42-4.42
High Estimate-0.67-0.57-2.35-1.65
Year Ago EPS-0.58-0.63-2.74-2.85
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts6688
Avg. EstimateN/AN/AN/A390k
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A3.09M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History2023-03-302023-06-292023-09-292023-12-30
EPS Est.-0.6-0.65-0.71-0.73
EPS Actual-0.58-0.63-0.66-0.86
Difference0.020.020.05-0.13
Surprise %3.30%3.10%7.00%-17.80%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.84-0.73-2.85-2.76
7 Days Ago-0.84-0.73-2.85-2.76
30 Days Ago-0.89-0.87-3.37-3.29
60 Days Ago-0.79-0.77-3.06-3.03
90 Days Ago-0.79-0.75-3.01-2.83
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1455
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesACRVIndustrySector(s)S&P 500
Current Qtr.-44.80%N/AN/AN/A
Next Qtr.-15.90%N/AN/AN/A
Current Year-4.00%N/AN/AN/A
Next Year3.20%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A